Nicole Labrosse - Net Worth and Insider Trading

Nicole Labrosse Net Worth

The estimated net worth of Nicole Labrosse is at least $908,986 dollars as of 2024-11-05. Nicole Labrosse is the SVP, CHIEF FINANCIAL OFFICER of Halozyme Therapeutics Inc and owns about 15,480 shares of Halozyme Therapeutics Inc (HALO) stock worth over $908,986. Details can be seen in Nicole Labrosse's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nicole Labrosse has not made any transactions after 2024-07-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Nicole Labrosse

To

Nicole Labrosse Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nicole Labrosse owns 1 companies in total, including Halozyme Therapeutics Inc (HALO) .

Click here to see the complete history of Nicole Labrosse’s form 4 insider trades.

Insider Ownership Summary of Nicole Labrosse

Ticker Comapny Transaction Date Type of Owner
HALO Halozyme Therapeutics Inc 2024-07-22 SVP & Chief Financial Officer

Nicole Labrosse Latest Holdings Summary

Nicole Labrosse currently owns a total of 1 stock. Nicole Labrosse owns 15,480 shares of Halozyme Therapeutics Inc (HALO) as of July 22, 2024, with a value of $908,986.

Latest Holdings of Nicole Labrosse

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HALO Halozyme Therapeutics Inc 2024-07-22 15,480 58.72 908,986

Holding Weightings of Nicole Labrosse


Nicole Labrosse Form 4 Trading Tracker

According to the SEC Form 4 filings, Nicole Labrosse has made a total of 4 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Halozyme Therapeutics Inc is the sale of 5,000 shares on July 22, 2024, which brought Nicole Labrosse around $269,650.

Insider Trading History of Nicole Labrosse

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nicole Labrosse Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nicole Labrosse Ownership Network

Ownership Network List of Nicole Labrosse

No Data

Ownership Network Relation of Nicole Labrosse

Insider Network Chart

Nicole Labrosse Owned Company Details

What does Halozyme Therapeutics Inc do?

Who are the key executives at Halozyme Therapeutics Inc?

Nicole Labrosse is the SVP & Chief Financial Officer of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & General Counsel Mark Howard Snyder .

Halozyme Therapeutics Inc (HALO) Insider Trades Summary

Over the past 18 months, Nicole Labrosse made 2 insider transaction in Halozyme Therapeutics Inc (HALO) with a net sale of 35,000. Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .

In summary, during the past 3 months, insiders sold 199,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 199,881 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.

Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Halozyme Therapeutics Inc Insider Transactions

No Available Data

Nicole Labrosse Mailing Address

Above is the net worth, insider trading, and ownership report for Nicole Labrosse. You might contact Nicole Labrosse via mailing address: 11388 Sorrento Valley Road, San Diego Ca 92121.